To provide for the collection and maintenance of human cord blood stem cells for the treatment of patients and research, and to amend the Public Health Service Act to authorize the C.W. Bill Young Cell Transplantation Program.
Sponsor and status
Sponsor. Representative for New Jersey's 4th congressional district. Republican.
Last Updated: Dec 19, 2005
Length: 14 pages
109th Congress, 2005–2006
Enacted — Signed by the President on Dec 20, 2005
This bill was enacted after being signed by the President on December 20, 2005.
H.R. 2520 (109th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 109th Congress, which met from Jan 4, 2005 to Dec 9, 2006. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 2520 — 109th Congress: Stem Cell Therapeutic and Research Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr2520
“H.R. 2520 — 109th Congress: Stem Cell Therapeutic and Research Act of 2005.” www.GovTrack.us. 2005. October 19, 2019 <https://www.govtrack.us/congress/bills/109/hr2520>
Stem Cell Therapeutic and Research Act of 2005, Pub. L. No. 109-129, H.R. 2520, 109th Cong..
|title=H.R. 2520 (109th)
|accessdate=October 19, 2019
|author=109th Congress (2005)
|date=May 23, 2005
|quote=Stem Cell Therapeutic and Research Act of 2005
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.